Arvinas (ARVN) Stock Highlights

22.69 | +4.85%

2024-11-21 03:02:46

Arvinas Inc is a United States-based private biopharmaceutical company focused on developing first-in-class protein degradation therapeutics for cancers and other difficult-to-treat diseases. The companys proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cells own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. Its pipeline candidates include metastatic castration-resistant prostate cancer, metastatic ER-breast cancer, additional oncology indications, tauopathies, and other neurodegenerative diseases. The groups product candidates are bavdegalutamide, ARV-471 and ARV-766.

Statistics

Range Today

21.17 22.71

Volume Today 744.1K

Range 1 Year

20.28 53.08

Volume 1 Year 190.21M

Range 3 Year

13.57 84.96

Volume 3 Year 421.04M

Range 10 Year

10.19 108.47

Volume 10 Year 740.82M

Highlights

Market Capitalization 1.86B (small)

Floating Shares 57.18M

Current Price 22.69

Price To Earnings -5.8

Price To Revenue 4.88

Price To Book 3.18

Earnings Per Share -4.79

Payout Ratio 0%

Performance

Latest +4.85%

1 Month -16.03%

3 Months -10.95%

6 Months -30.68%

1 Year +2.02%

3 Years -72.66%

5 Years -30.68%

10 Years +8.05%

Benchmarks

Market Capitalization

56 / 368

Gross Profits

42 / 278

Total Revenue

68 / 300

Total Rank

293 / 368

Free Cashflow

202 / 352

Performance 5 years

142 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.